ERS Genomics

88 Harcourt Street
Dublin 2

Tel: +353-01-539-0082

Email: info@ersgenomics.com

Show jobs for this employer

About ERS Genomics

ERS Genomics was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property held by co-inventor and co-owner Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use.
CRISPR-Cas9 is a revolutionary new genome editing technology, which offers significant advantages in speed, efficiency and cost over earlier genome editing methods.
YEAR FOUNDED:
2013
LEADERSHIP:
Scientific Advisor and Co-Founder: Dr. Emmanuelle Charpentier
Chairman of the Board and Co-Founder: Shaun Foy
CEO: Eric Rhodes
TECHNOLOGY:
Please click here for ERS Genomics' technology.

63 articles with ERS Genomics